TMEM105 and breast carcinoma: The results revealed that the injection of TMEM105-overexpressing or knockdown breast cancer cells promoted or suppressed the human genomic DNA in the livers, and these effects were reversed after cotransfection with miR-1208 mimics or inhibitors (Fig. 7E–G).